173 related articles for article (PubMed ID: 16801424)
1. Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.
Ponte-Sucre A; Vicik R; Schultheis M; Schirmeister T; Moll H
Antimicrob Agents Chemother; 2006 Jul; 50(7):2439-47. PubMed ID: 16801424
[TBL] [Abstract][Full Text] [Related]
2. Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
Schad C; Baum U; Frank B; Dietzel U; Mattern F; Gomes C; Ponte-Sucre A; Moll H; Schurigt U; Schirmeister T
Antimicrob Agents Chemother; 2016 Feb; 60(2):797-805. PubMed ID: 26596939
[TBL] [Abstract][Full Text] [Related]
3. Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
Ponte-Sucre A; Faber JH; Gulder T; Kajahn I; Pedersen SE; Schultheis M; Bringmann G; Moll H
Antimicrob Agents Chemother; 2007 Jan; 51(1):188-94. PubMed ID: 17088484
[TBL] [Abstract][Full Text] [Related]
4. Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles.
Schurigt U; Schad C; Glowa C; Baum U; Thomale K; Schnitzer JK; Schultheis M; Schaschke N; Schirmeister T; Moll H
Antimicrob Agents Chemother; 2010 Dec; 54(12):5028-41. PubMed ID: 20855728
[TBL] [Abstract][Full Text] [Related]
5. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
[TBL] [Abstract][Full Text] [Related]
6. Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.
Vicik R; Hoerr V; Glaser M; Schultheis M; Hansell E; McKerrow JH; Holzgrabe U; Caffrey CR; Ponte-Sucre A; Moll H; Stich A; Schirmeister T
Bioorg Med Chem Lett; 2006 May; 16(10):2753-7. PubMed ID: 16516467
[TBL] [Abstract][Full Text] [Related]
7. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
[TBL] [Abstract][Full Text] [Related]
8. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
11. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells.
Kolodziej H; Kiderlen AF
Phytochemistry; 2005 Sep; 66(17):2056-71. PubMed ID: 16153409
[TBL] [Abstract][Full Text] [Related]
13. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
[TBL] [Abstract][Full Text] [Related]
14. Effects of amidine derivatives on parasite-macrophage interaction and evaluation of toxicity.
Temporal RM; Cysne-Finkelstein L; Echevarria A; de Souza MA; Sertà M; da Silva-Gonçalves AJ; Pirmez C; Leon LL
Arzneimittelforschung; 2002; 52(6):489-93. PubMed ID: 12109051
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T
Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628
[TBL] [Abstract][Full Text] [Related]
16. Cysteine protease inhibitors as chemotherapy: lessons from a parasite target.
Selzer PM; Pingel S; Hsieh I; Ugele B; Chan VJ; Engel JC; Bogyo M; Russell DG; Sakanari JA; McKerrow JH
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11015-22. PubMed ID: 10500116
[TBL] [Abstract][Full Text] [Related]
17. Nano-based antileishmanial agents: a toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis.
Jebali A; Kazemi B
Toxicol In Vitro; 2013 Sep; 27(6):1896-904. PubMed ID: 23806227
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts.
Ponte-Sucre A; Gulder T; Wegehaupt A; Albert C; Rikanović C; Schaeflein L; Frank A; Schultheis M; Unger M; Holzgrabe U; Bringmann G; Moll H
J Med Chem; 2009 Feb; 52(3):626-36. PubMed ID: 19117415
[TBL] [Abstract][Full Text] [Related]
19. Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones.
Nazarian Z; Emami S; Heydari S; Ardestani SK; Nakhjiri M; Poorrajab F; Shafiee A; Foroumadi A
Eur J Med Chem; 2010 Apr; 45(4):1424-9. PubMed ID: 20074836
[TBL] [Abstract][Full Text] [Related]
20. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
